Genflow Biosciences PLC Announces Primary Endpoint in SLAB Clinical Trial Met

September 8, 2026 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), a biotechnology company focused on the development of gene therapies for age-related diseases, announces that its SLAB (Sarcopenia and Longevity in Aged Beagles) clinical trial, evaluating its proprietary SIRT6 centenarian gene therapy in aged dogs, has met its primary endpoint. The Company further announces that detailed results from the completed trial will be...

Read more

Philip Ashton-Rickardt Explores Why Reinvention Matters in a Scientific Career

September 7, 2026 7:20 PM

Philip Ashton-Rickardt has spent much of his career working in environments where change is constant. From academic research to biotech entrepreneurship, his path has included major shifts in role, responsibility, and focus.For Ashton-Rickardt, reinvention has not meant abandoning one career for another. It has meant building on what came before while being willing to move in a new direction.He began his career in academic science after earning...

Read more

Healthcare Leaders Gain Complimentary Access to Global Research for 2027 Technology Planning

September 7, 2026 11:45 AM

Black Book Research is making several 2026 industry research libraries available at no charge to global healthcare industry stakeholders through December 31, 2026, broadening access to technology insights as provider and payer organizations prepare their next budgets, investment priorities and implementation plans.The initiative presents over 20 curated collections organized around leadership responsibilities, tech disciplines and geographic...

Read more

From Barriers to Bridges: Expanding Access to Healthcare in Kenya

September 7, 2026 9:35 AM

In Kenya, managing chronic disease often means navigating cost, distance, and uncertainty-every single time. These barriers make consistent care difficult to sustain for many patients. Through a collaborative Access to Healthcare program, partners build pathways to affordable, continuous care.For thousands of people living with type 2 diabetes or hypertension in Kenya, managing their condition is not just about medical advice or prescriptions....

Read more

Further Analysis of the Phase 2b ADVANCE Study Reinforces Phase 2b EXPAND Results and Supports Phase 3 Development - FDA Discussions on Trial Design Planned for Q4 2026

September 7, 2026 5:15 AM

SynAct Pharma AB (publ) ("SynAct")(STO:SYNACT), a clinical-stage biotechnology company focused on treating inflammation through a novel therapeutic approach known as "pro-resolution", today announced results from a post-hoc analysis of the Phase 2b ADVANCE study evaluating resomelagon in treatment-naïve patients with highly active rheumatoid arthritis ("RA"). The analysis reinforces the positive results from the earlier Phase 2b EXPAND study and...

Read more

On Labor Day, Guardian Angel AI Turns Attention to America's $1 Trillion Unpaid Workforce: Family Caregivers

September 7, 2026 5:00 AM

Labor Day recognizes the work that keeps America running. But one of the country's largest workforces will largely go unrecognized. They are the sons, daughters, spouses and relatives caring for aging family members at home.According to research from AARP and the National Alliance for Caregiving, 63 million Americans now provide ongoing care for a loved one. Fifty-nine million are caring for adults. A separate 2026 AARP analysis estimated that...

Read more

Genflow Biosciences PLC Announces Appointment of Investor Relations Adviser

September 7, 2026 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), an emerging leader in the field of longevity research, today announces the appointment of ON365 Partners Inc. ("ON365") as the Company's investor relations adviser, with immediate effect. ON365 succeeds Harbor Access, which has supported the Company's investor relations activities to date.ON365 is a specialist investor relations and strategic advisory firm focused on...

Read more

BioEdge Research Labs Expands Independent Analytical Testing Program

September 4, 2026 6:15 PM

BioEdge Research Labs, a United States-based supplier of research peptides and reference materials, today announced an expansion of its independent analytical testing program. The expanded program broadens the analytical testing and batch-level documentation that accompany the company's research-use-only materials, reinforcing an approach built on verifiable, laboratory-grade documentation.Independent analytical testing and verifiable records...

Read more

SEEN Vision Care Expands Eye and Skin Care Services with Tixel Technology

September 4, 2026 2:30 PM

SEEN Vision Care, a Michigan eye care practice serving patients in Dearborn Heights and surrounding communities, today announced the addition of Tixel for Dry Eye and Tixel for Youthful Eyes to its clinical services. The new treatment options reflect the practice's broader approach to eye care, addressing both ocular surface health and concerns involving the skin around the eyes.Led by Dr. BK Wahab, OD, MBA, SEEN Vision Care takes a...

Read more

DaVita Community Care Report 2025: Leading With Integrity and Accountability

September 4, 2026 12:20 PM

At DaVita, doing the right thing and conducting business activities with the highest standards of ethics is foundational to our culture. We are firmly committed to compliance with our policies and all applicable laws and regulations. (Learn more about our Code of Conduct.)Beyond navigating complex regulations, DaVita's compliance program empowers teammates to champion ethical standards in everyday decisions. In 2025 alone, we delivered more than...

Read more

Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026

September 4, 2026 11:15 AM

Champions Oncology, Inc. (CSBR), a global leader in clinically relevant oncology research models and translational solutions, will report its financial and operational results for the quarter ended July 31, 2026, on Thursday, September 10, 2026, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International)...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Activates Volunteer Intake for Melanoma Scan Beta After Launching First Human-Submitted Dataset Initiative

September 4, 2026 8:57 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced that volunteer intake is now active for the first human-submitted image cohort supporting MDCE Melanoma Scan Beta - advancing the initiative first announced on August 31, 2026. On August 31, the Company said it was seeking its first volunteers in order to move beyond testing and training based solely on established public cancer imaging datasets, including HAM10000, ISIC Archive...

Read more

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

September 4, 2026 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that Jaguar family company Napo Pharmaceuticals (Napo) is providing the company's novel crofelemer powder for oral solution for treatment of intestinal failure (IF) in an infant patient due to congenital sodium diarrhea (CSD), which is caused by a mutation in the GUCY2C gene.Napo remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy...

Read more

Living With Primary Immunodeficiency: How Specialty Care Supports Nick's Journey

September 4, 2026 8:30 AM

Nick Stacken loves sports. In fact, he's been a Special Olympian in his state for two decades. Now his sights are set on participating at the national level.Learn more about Nick's story here.For his mother and caregiver, Wendy Stacken, that future once seemed impossible."Nick was born with multiple health issues," Wendy recalls. "He kept getting sick. We'd take him to the hospital and we'd be back again hours later. It was terrifying."At 13...

Read more

Healthcare IT Transformation Is Now an Execution Problem, 2026 Black Book Surveys Show

September 4, 2026 8:18 AM

Healthcare organizations have spent heavily on data platforms, interoperability, automation and artificial intelligence. Yet across Black Book Research's 2026 provider and payer studies, the same conclusion continues to surface: acquiring the technology is increasingly the easier part. Making it work across real healthcare operations is the transformation challenge.Throughout 2026, Black Book has supported providers, payers, healthcare...

Read more

Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump

September 4, 2026 8:00 AM

Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that it has secured a contract with a national U.S. pharmacy benefit manager (PBM) in the United States. Pursuant to the contract, the Company's Pivot insulin delivery system is now available through the national PBM. The Company...

Read more

As Leaves Change, So Do Goals: Dr. David Pincus on Why Fall Is Prime Season for Cosmetic Surgery

September 3, 2026 7:25 PM

As temperatures drop and schedules settle after summer travel, Pincus Plastic Surgery is seeing a familiar pattern take shape. Fall has become one of the busiest times of year for consultations, and Dr. David Pincus says the timing is no coincidence.A Seasonal Pattern Worth NoticingEvery year, the practice notices the same shift once autumn arrives. Patients who spent the summer thinking about a procedure finally pick up the phone. Others simply...

Read more

Istanbul Care Unveils All-Inclusive 2026 Hair Transplant Packages Featuring Fixed Pricing and Individualized Clinical Care

September 3, 2026 5:07 PM

Medical tourism provider Istanbul Care today announced its 2026 operational protocol for international hair restoration patients. Designed to replace opaque per-graft pricing models, the clinic's updated offering integrates all-inclusive flat-rate pricing with standardized, doctor-led clinical assessment and long-term post-operative monitoring.Istanbul Care Unveils All-Inclusive 2026 Hair Transplant Packages Featuring Fixed Pricing and...

Read more

Pro-Dex, Inc. Announces Fiscal 2026 Fourth Quarter and Full-Year Results

September 3, 2026 4:00 PM

PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 fourth quarter and full-year ended June 30, 2026.Quarter Ended June 30, 2026Net sales for the three months ended June 30, 2026 increased $2.9 million, or 17%, to $20.4 million from $17.5 million for the three months ended June 30, 2025, due primarily to increased revenue from our largest customer's next generation orthopedic handpiece. Gross profit for the three...

Read more

Odyssey Behavioral Healthcare Marks 10 Years with Measurable Clinical Outcomes Across Mental Health, Substance Use and Eating Disorder Programs

September 3, 2026 1:00 PM

Odyssey Behavioral Healthcare today released its 2025 clinical outcomes, marking 10 years of measurable, data-driven care across its specialized mental health, substance use and eating disorder programs since the organization's founding in 2015.Across Odyssey's residential eating disorder programs, clients experienced an average 59% reduction in eating disorder symptom severity over the measured period. Across its mental health and substance use...

Read more